Insider Trading

OSTX Stock   3.02  1.44  32.29%   
Slightly above 62% of OS Therapies' investor base is looking to short. The analysis of the overall investor sentiment regarding OS Therapies Incorporated suggests that many traders are alarmed. OS Therapies' investing sentiment can be driven by a variety of factors including economic data, OS Therapies' earnings reports, geopolitical events, and overall market trends.
  
Filed transaction by OS Therapies Incorporated Director. Insider Public Trading

Read at macroaxis.com
OSTX insider trading alert for general transaction of common stock, par value $0.001 per share by Mckean-dieser Avril Suzette, Director, on 28th of October 2024. This event was filed by OS Therapies Incorporated with SEC on 2024-10-28. Initial filing of beneficial ownership - SEC Form 3

Cash Flow Correlation

OS Therapies' cash-flow correlation analysis can be used to evaluate the unsystematic risk during the given period. It also helps investors identify the OS Therapies' relationships between the major components of the statement of changes in financial position and other commonly used cash-related accounts. When such correlations are discovered, they may help managers and analysts to enhance performance or determine appealing investment opportunities.
Click cells to compare fundamentals

OS Therapies Fundamental Analysis

We analyze OS Therapies' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of OS Therapies using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of OS Therapies based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Retained Earnings

Retained Earnings Comparative Analysis

OS Therapies is currently under evaluation in retained earnings category among its peers. Retained Earnings is a balance sheet account that refers to the portion of company income that is retained by the firm. In other words, it is a part of earnings that is not paid out as dividends or otherwise distributed to owners. Retained Earnings are calculated by adding net income to last period retained earnings and subtracting any dividends paid to owners.

OS Therapies Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with OS Therapies stock to make a market-neutral strategy. Peer analysis of OS Therapies could also be used in its relative valuation, which is a method of valuing OS Therapies by comparing valuation metrics with similar companies.

Additional Tools for OSTX Stock Analysis

When running OS Therapies' price analysis, check to measure OS Therapies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy OS Therapies is operating at the current time. Most of OS Therapies' value examination focuses on studying past and present price action to predict the probability of OS Therapies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move OS Therapies' price. Additionally, you may evaluate how the addition of OS Therapies to your portfolios can decrease your overall portfolio volatility.